SRI International To Highlight Pathway Tools Capabilities At The Molecular Medicine Tri-Conference In San Francisco, March 25 - 28
Main Category: Biology / BiochemistryAlso Included In: Conferences
Article Date: 26 Mar 2008 - 2:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
SRI International, an independent nonprofit research and development organization, announced that more than 75 research groups are now using its Pathway Tools bioinformatics software to create pathway databases for organisms with sequenced genomes. In addition, more than 1,300 academic and commercial groups have licensed SRI's Pathway Tools software to access existing databases.
"From microbes to mouse, from metabolic engineering to drug discovery, we're seeing strong growth in Pathway Tools usage across the life sciences," said Peter Karp, Ph.D., director of SRI's Bioinformatics Research Group. "Hundreds of pathway databases now share a common schema, which will facilitate data sharing and comparative analyses." Several of these pathway database efforts will be highlighted at a session at the Molecular Medicine Tri-Conference to be held in San Francisco from March 25-28, 2008. Speakers will describe the development of Pathway Tools based pathway databases for major biomedical model organisms including the baker's yeast Saccharomyces cereivisae, the soil-living amoeba Dictyostelium discoideum, and the laboratory mouse; and for the Euasterid clade of plants that includes tomato, potato, pepper, and coffee.
Dr. Karp will share recent developments in Pathway Tools including:
-- A new genome-scale visualization tool for cellular regulatory networks
-- A tool for predicting chokepoints in metabolic networks that may constitute good anti-microbial drug targets
-- New comparative analysis capabilities including a comparative genome browser and pathway and transport comparisons
-- An advanced but intuitive method of formulating complex queries to pathway databases
The development of SRI's Pathway Tools has been funded by grants from the National Institutes of Health (NIH), including the National Institute of Allergy and Infectious Diseases (NIAID). SRI's Pathway Tools are used by two NIAID Bioinformatics Resource Centers, Pathema and the PathoSystems Resource Integration Center (PATRIC), to analyze the genomes of infectious disease pathogens. Other groups are developing plant pathway databases for the flowering plants Arabidopsis and Medicago, rice, and other plants.
SRI's Pathway Tools software has a range of capabilities, including prediction of metabolic pathways from genome data, visual display of both individual pathways and the entire metabolic network, and connectivity analysis of metabolic networks. It also provides a complete pathway editing and curation environment. Visual representation of the biochemical network of an organism aids the interpretation of large-scale omics datasets.
A recent breakthrough in Pathway Tools is its ability to automatically generate metabolic wall charts from any Pathway Tools database. This advanced layout algorithm allows users to generate organism-specific metabolic charts more detailed and accurate than traditional metabolic charts found in biology labs worldwide. Such charts can be generated for many organisms, including the 370 organisms for which pathway databases have been developed in SRI's BioCyc database collection at http://www.BioCyc.org. As the various databases are updated to reflect evolving knowledge of the metabolism of an organism, SRI's software technology can immediately generate updated charts.
Pathway Tools software is free to academic or non-profit institutions for research use. A fee applies to other forms of use. Pathway Tools will be available for the Apple Macintosh for the first time in April 2008. See http://biocyc.org/download.shtml for more details and download instructions.
About SRI International
Silicon Valley-based SRI International is one of the world's leading independent research and technology development organizations. Founded as Stanford Research Institute in 1946, SRI has been meeting the strategic needs of clients for 60 years. The nonprofit research institute performs client-sponsored research and development for government agencies, commercial businesses, and private foundations. In addition to conducting contract R&D, SRI licenses its technologies, forms strategic partnerships, and creates spin-off companies.
SRI International
Visit our biology / biochemistry section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/101642.php>
APA
http://www.medicalnewstoday.com/releases/101642.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



